Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Cytotherapy|March 21, 2019
Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapiesBen Weil, Patrick J Hanley, Mark LowdellBritish Journal of Haematology|July 9, 2002
Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftmentMickey B C Koh, H Grant Prentice, Marguerite Corbo, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activationJanet North, Ismail Bakhsh, Chloe Marden, et al.Regenerative Medicine|November 29, 2014
Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissuesJonathan M Fishman, Justin C R Wormald, Mark W Lowdell, et al.The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.Materials Science & Engineering. C, Materials for Biological Applications|September 7, 2018
Silsesquioxane polymer as a potential scaffold for laryngeal reconstructionNazia Mehrban, James Bowen, Angela Tait, et al.British Journal of Haematology|June 13, 2002
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cellsMark W Lowdell, Rose Craston, David Samuel, et al.Cytotherapy|June 5, 2016
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapyZhengqiang Yuan, Sofia Da Silva Lourenco, Elizabeth K Sage, et al.Blood|June 26, 2010
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantationAndrea Knight, Alejandro J Madrigal, Sarah Grace, et al.Tissue Engineering|September 14, 2006
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valvesPuspa Batten, Padmini Sarathchandra, Joseph W Antoniw, et al.Pageof 8